Important Reminder for APLT Investors About Class Action Lawsuit Deadline Approaching Soon

Important Notice for APLT Investors

As the deadline of February 18, 2025, approaches, investors in Applied Therapeutics, Inc. (NASDAQ: APLT) should be aware of a class action lawsuit filed on their behalf by the law firm Kessler Topaz Meltzer & Check, LLP. This action stems from allegations made against the company regarding their clinical trials and product integrity.

Details Surrounding the Lawsuit

The lawsuit has been initiated in the United States District Court for the Southern District of New York and focuses on those who acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, known as the "Class Period." The firm's primary assertion is that throughout this Class Period, the defendants disclosed misleading information and failed to conform to the required trial protocols and sound clinical practices relating to their drug candidate, govorestat. This negligence has perpetuated concerns that vital trial data may eventually face rejection by the FDA when applications for new drugs are filed.

Individuals who believe they may have suffered losses as a result of investing in Applied Therapeutics are strongly encouraged to consider the opportunity to participate in this case. Interested investors must take action before the approaching lead plaintiff deadline on February 18, 2025. They can become lead plaintiffs representing the class or remain passive members of the group.

Understanding the Lead Plaintiff Process

Being appointed as a lead plaintiff involves selecting representatives who will guide the litigation on behalf of the entire class. A lead plaintiff typically comes from the investor group and is characterized by having a substantial financial stake in the matter while providing adequate representation for other affected investors. Those who opt to serve in this role will have the chance to select attorneys to lead the representation. Notably, if you choose not to pursue this option as the lead plaintiff, your rights to any potential recovery are unaffected.

For more details or to express interest in participation, investors can visit Kessler Topaz Meltzer & Check, LLP's official website or directly reach out to their attorneys for consultations on the available options.

About Kessler Topaz Meltzer & Check, LLP

This reputable law firm has built a strong legacy prosecuting class actions both in the U.S. and internationally. Their work is driven by a commitment to protecting investors and consumers from fraudulent activities, which has resulted in recovering billions of dollars for countless victims of corporate misconduct. Their extensive experience presents potential class members with an exceptional opportunity for advocacy in pursuing justice.

For more information, potential investors can contact Jonathan Naji, Esq. at Kessler Topaz Meltzer & Check, LLP via phone at (484) 270-1453 or email at [email protected].

Conclusion

Investors should stay well-informed about the developments surrounding the lawsuit and have the necessary resources to seek assistance if they have sustained losses within the outlined time frame. Engaging with professional legal counsel is crucial to decoding the complexities associated with this class action and ensuring equitable representation moving forward.